Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Am J Psychiatry. 2017 Dec 5;175(4):327–335. doi: 10.1176/appi.ajp.2017.17060647

TABLE 1.

Baseline Characteristics of Patients with Major Depressive Disorder and Clinically Significant Suicidal Ideation Given a Single Infusion of Ketamine or Midazolama

Midazolam
(N=40)
Ketamine
(N=40)
Variableb N % N % χ2 df p
Female sex 26 65 22 55 0.83 1 0.36
White race 39 97.5 35 87.5 0.20h
Hispanic ethnicity 1 2.5 0 0 1.0h
Married 7 18 7 18 0.00 1 0.96
Currently employed 15 37.5 10 25 1.46 1 0.23
Prior psychiatric hospitalization 29 73 27 68 0.24 1 0.63
Prior suicide attemptc 22 55 17 42.5 1.25 1 0.26
Personality disorderd 13 36 16 41 0.19 1 0.66
Borderline personality disorderd 3 8 11 28 4.87 1 0.03
Alcohol or substance use disorder history 9 22.5 11 27.5 0.27 1 0.61
Mood disorder in first degree relative 23 57.5 24 60.0 0.052 1 0.82
Suicide or attempt in first degree relative 3 7.5 2 5.0 1.0h
Variable N Mean ± SD N Mean ± SD t df p
Age 40 40.7 ±13.1 40 38.4 ±13.2 0.77 78 0.44
Scale for Suicidal Ideatione 40 15.7 ±6.9 40 14.3 ±6.3 0.94 78 0.35
Hamilton Depression Rating Scale (17 item)f 40 22.6 ±3.9 40 22.2 ±4.6 0.41 78 0.68
Beck Depression Inventoryg 38 33.9 ±8.1 36 31.8 ±8.1 1.13 72 0.26
Total years of education 39 15.9 ±2.4 40 15.9 ±2.8 0.04 77 0.97
Variable Median (range) Median (range) Ui p
Length of current episode (weeks) 37 50 (2–2860) 36 60 (8–572) 652.0 0.88
Age of onset of first major depressive episode (years) 39 14 (5–45) 37 16 (6–51) 744.5 0.81
Lifetime number of major depressive episodes including current 35 3 (1-too many to count) 36 4.5 (1-too many to count) 716.5 0.31
Body mass index 40 27.8 (17.2–51.5) 40 25.3 (19.9–46.7) 708.0 0.38
a

Modified intention-to-treat sample.

b

Assessed with our research Baseline Clinical-Demographic form unless otherwise noted.

c

Columbia Suicide History Interview (48).

d

SCID for DSM-IV Axis II disorders (27).

e

Score ranges from 0 to 38, with higher scores indicating greater symptom severity.

f

Score ranges from 0 to 53, with higher scores indicating greater symptom severity.

g

Score ranges from 0 to 63, with higher scores indicating greater symptom severity.

h

Fisher’s Exact Test

i

Mann-Whitney U